Abstract
Acute coronary syndrome (ACS) is a term for a range of clinical signs and symptoms suggestive of myocardial ischemia. It results in functional and structural changes and ultimately releasing protein from injured cardiomyocytes. These cardiac markers play a major role in diagnosis and prognosis of ACS. This study aims to assess the efficacy of heart type fatty acid binding protein (h-FABP) as a marker for ACS along with the routinely used hs-TropT. In our observational study, plasma h-FABP (cut-off 6.32 ng/ml) and routinely done hs-Trop T (cutoff 0.1 and 0.014 ng/ml) were estimated by immunometric laboratory assays in 88 patients with acute chest pain. Based on the clinical and laboratory test findings the patients were grouped into ACS (n = 41) and non-ACS (n = 47). The diagnostic sensitivity, specificity, NPV, PPV and ROC curve at 95 % CI were determined. Sensitivity of hs-TropT (0.1 ng/ml), hs-TropT (0.014 ng/ml) and h-FABP were 53, 86 and 78 % respectively and specificity for the same were 98, 73 and 70 % respectively. Sensitivity, specificity and NPV calculated for a cut-off combination of hs-TropT 0.014 ng/ml and h-FABP was 100, 51 and 100 % respectively. These results were substantiated by ROC analysis. Measurement of plasma h-FABP and hs-TropT together on admission appears to be more precise predictor of ACS rather than either hs-Trop T or h-FABP.
Similar content being viewed by others
References
Morrow D, Cannon C, Jesse R, Newby L, Ravkilde J, Storrow A, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115(13):e356–75.
Nagesh C, Roy A. Role of biomarkers in risk stratification of acute coronary syndrome. Indian J Med Res. 2010;132:627.
Body R, McDowell G, Carley S, Wibberley C, Ferguson J, Mackway-Jones K. A FABP-ulous ‘rule out’ strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. Resuscitation. 2011;82(8):1041–6.
Nusier M, Ababneh B. Diagnostic efficiency of creatine kinase (CK), CKMB, troponin T and troponin I in patients with suspected acute myocardial infarction. J Health Sci. 2006;52(2):180–5.
Bass N. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol. 1988;111:143–84.
Viswanathan K, Hall A, Barth J. An evidence-based approach to the assessment of heart-type fatty acid binding protein in acute coronary syndrome. Clin Biochem Rev. 2012;33:3–11.
Ruzgar O, Bilge A, Bugra Z, Umman S, Yilmaz E, Ozben B, et al. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase–myocardial band. Heart Vessels. 2006;21(5):309–14.
Ishii J, Ozaki Y, Lu J, Kitagawa F, Kuno T, Nakano T, et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem. 2005;51(8):1397–404.
Colli A, Josa M, Pomar J, Mestres C, Gherli T. Heart fatty acid binding protein in the diagnosis of myocardial infarction: where do we stand today? Cardiology. 2007;108(1):4.
Gururajan P, Gurumurthy P, Nayar P, Rao GSN, Babu S, Cherian K. Heart fatty acid binding protein (H-FABP) as a diagnostic biomarker in patients with acute coronary syndrome. Heart Lung Circ. 2010;19(11):660–4.
Niizeki T, Takeishi Y, Takabatake N, Shibata Y, Konta T, Kato T, et al. Circulating levels of heart-type fatty acid-binding protein in a general Japanese population. Circ J. 2007;71(9):1452–7.
Slot MB, van der Heijden G, Rutten F, van der Spoel O, Mast E, Bredero A, et al. Heart-type fatty acid-binding protein in acute myocardial infarction evaluation (FAME): background and design of a diagnostic study in primary care. BMC Cardiovasc Disord. 2008;8(1):8.
Mad P, Domanovits H, Fazelnia C, Stiassny K, Russmuller G, Cseh A, et al. Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM. 2007;100(4):203–10.
Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite S, Sivananthan M, Hassan T, et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol. 2010;55(23):2590–8.
McMahon C, Lamont J, Curtin E, McConnell R, Crockard M, Kurth M, et al. Diagnostic accuracy of heart-type fatty acid–binding protein for the early diagnosis of acute myocardial infarction. Ame J Emerg Med. 2012;30(2):267–74.
Haltern G, Peiniger S, Bufe A, Reiss G, Gülker H, Scheffold T. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am J Cardiol. 2010;105(1):1–9.
Nakata T, Hashimoto A, Hase M, Tsuchihashi K, Shimamoto K. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology. 2003;99(2):96–104.
Ramaiah JH, Ramegowda TR, Ashalatha B, Ananthakrishna R, Nanjappa CM. Heart-type fatty acid-binding protein (h-fabp) as a novel biomarker for the early diagnosis of acute myocardial infarction in comparison with cardiac troponin T. J Evol Med Dent Sci. 2013;2(1):8–18.
Acknowledgments
We acknowledge P. D Hinduja National Hospital & Medical Research Centre for their continued encouragement and Randox laboratories India Pvt. Ltd. for support in terms of reagents for the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reddy, L.L., Shah, S.A.V., Dherai, A.J. et al. Troponin T and Heart Type Fatty Acid Binding Protein (h-Fabp) as Biomarkers in Patients Presenting with Chest Pain. Ind J Clin Biochem 31, 87–92 (2016). https://doi.org/10.1007/s12291-015-0492-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-015-0492-2